Azithromycin and Pregnancy: Risks, Benefits & Safety Information

Azithromycin (a macrolide) treats community‑acquired pneumonia, chlamydia, and other infections. In pregnancy, it is FDA Category B (animal studies show no risk; human data limited but reassuring).

Potential Concerns

  • Cardiac Effects: Prolongs QT interval; caution with other QT‑prolonging drugs or congenital long QT syndrome.
  • Infantile Hypertrophic Pyloric Stenosis (IHPS): Some studies associate macrolide use in first 2 weeks of life (or late pregnancy) with IHPS; absolute risk low.
  • Hepatotoxicity: Rare; monitor if pre‑existing liver disease.

Clinical Decision

Benefits of treating a significant infection (chlamydia, pneumonia) usually outweigh theoretical risks. Untreated infections pose greater fetal/maternal danger. Always discuss with your obstetrician—alternative antibiotics (penicillins, cephalosporins) may be preferred for certain indications.

Do not self‑medicate; take exactly as prescribed; complete the course.

Pregnancy & Health - Related Articles